Impact of mass distribution of azithromycin on the antibiotic susceptibilities of ocular Chlamydia trachomatis

Antimicrob Agents Chemother. 2005 Nov;49(11):4804-6. doi: 10.1128/AAC.49.11.4804-4806.2005.

Abstract

In a community of Tanzania where trachoma is endemic, we cultured conjunctival swabs from all residents who had active trachoma and were PCR positive for ocular Chlamydia trachomatis, both before (43 isolates) and 2 months after (9 isolates) mass antibiotic treatment. No clinically or programmatically significant increase in azithromycin or tetracycline resistance was observed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Azithromycin / pharmacology*
  • Azithromycin / therapeutic use
  • Chlamydia trachomatis / drug effects*
  • Drug Resistance, Bacterial
  • Eye / microbiology
  • Humans
  • Microbial Sensitivity Tests
  • Trachoma / drug therapy*

Substances

  • Azithromycin